TABLE 2.
Comparison of the clinical remission rates (where urine protein decreased by ≥ 50% at 3, 6, and 9 months of treatment) among the three groups of patients.
| Group | Time | Time point remission rate (cross-sectional) | KM cumulative remission rate |
|---|---|---|---|
| Support group | 3 months | 22.4% (15/67) | 22.4% |
| 6 months | 32.8% (22/67) | 40.3% | |
| 9 months | 41.8% (28/67) | 50.7% | |
| Glucocorticoids group | 3 months | 33.3% (14/42) | 33.3% |
| 6 months | 47.6% (20/42) | 52.4% | |
| 9 months | 52.4% (22/42) | 64.3% | |
| Nefecon group | 3 months | 37.5% (15/40) | 37.5% |
| 6 months | 52.5% (21/40) | 55.0% | |
| 9 months | 70.0% (28/40) | 77.5% |